Squarepoint Ops LLC - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 123 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,250,964
+11.9%
83,901
-17.9%
0.00%0.0%
Q2 2023$1,118,356
+36.6%
102,133
+8.8%
0.00%0.0%
Q1 2023$818,651
+1202.2%
93,882
+836.3%
0.00%
Q4 2022$62,869
+3.1%
10,027
-42.7%
0.00%
Q3 2022$61,000
+74.3%
17,495
+70.3%
0.00%
Q4 2021$35,000
-31.4%
10,273
-26.6%
0.00%
Q3 2021$51,000
-72.9%
13,995
-67.5%
0.00%
-100.0%
Q2 2021$188,000
-36.1%
43,127
-33.3%
0.00%
-50.0%
Q1 2021$294,000
-66.7%
64,671
-57.9%
0.00%
-71.4%
Q4 2020$882,000
+132.1%
153,593
+192.6%
0.01%
+40.0%
Q3 2020$380,000
-60.1%
52,501
-80.8%
0.01%
-66.7%
Q2 2020$953,000
+258.3%
273,172
+52.1%
0.02%
+114.3%
Q1 2020$266,000
+10.8%
179,573
+46.6%
0.01%
+600.0%
Q4 2019$240,000
-86.4%
122,532
-64.5%
0.00%
-93.8%
Q3 2019$1,765,000
+194.2%
344,735
+662.8%
0.02%
+166.7%
Q1 2019$600,000
+103.4%
45,195
+23.6%
0.01%0.0%
Q3 2017$295,000
+186.4%
36,570
+105.4%
0.01%
+200.0%
Q2 2017$103,000
-22.6%
17,800
-42.6%
0.00%
-50.0%
Q1 2017$133,00031,0000.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$11,887,0008.85%
Foresite Capital Management IV, LLC 1,787,094$12,939,0002.92%
Copernicus Capital Management, LLC 278,416$2,016,0001.92%
Sio Capital Management, LLC 1,159,236$8,393,0001.66%
ACUTA CAPITAL PARTNERS, LLC 765,000$5,539,0001.50%
Avoro Capital Advisors LLC 10,300,000$74,572,0001.06%
Boxer Capital, LLC 4,000,000$28,960,0001.00%
Vivo Capital, LLC 2,089,356$15,127,0000.87%
EAM Global Investors LLC 284,534$2,060,0000.76%
Versant Venture Management, LLC 543,753$3,937,0000.72%
View complete list of CYMABAY THERAPEUTICS INC shareholders